ArcBest Corp
NASDAQ:ARCB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
93.54
151.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
ArcBest Corp
Wall Street
Price Targets
ARCB Price Targets Summary
ArcBest Corp
According to Wall Street analysts, the average 1-year price target for
ARCB
is 124.78 USD
with a low forecast of 106.05 USD and a high forecast of 178.5 USD.
ARCB Last Price Targets
ArcBest Corp
The latest public price target was made on Oct 9, 2024 by
Ariel Rosa
from
Citigroup
,
who expects
ARCB
stock to
rise by 17%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Ariel Rosa
Citigroup
|
111
USD
Upside 17% |
2 months ago
Oct 9, 2024
|
This Chewy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga
|
Bruce Chan
Stifel Nicolaus
|
131
USD
Upside 38% |
4 months ago
Aug 6, 2024
|
ArcBest Corp (ARCB) PT Lowered to $131 at Stifel
StreetInsider
|
Ravi Shanker
Morgan Stanley
|
176
USD
Upside 86% |
5 months ago
Jul 8, 2024
|
ArcBest price target lowered to $176 from $180 at Morgan Stanley
TheFly
|
|
Bruce Chan
Stifel Nicolaus
|
150
USD
Upside 59% |
7 months ago
May 14, 2024
|
ArcBest Corp (ARCB) PT Lowered to $150 at Stifel
StreetInsider
|
Thomas Wadewitz
UBS
|
126
USD
Upside 33% |
7 months ago
May 1, 2024
|
ArcBest price target lowered to $126 from $150 at UBS
TheFly
|
|
Bruce Chan
Stifel Nicolaus
|
134
USD
Upside 42% |
1 year ago
Aug 1, 2023
|
ArcBest Set For Growth Amid Industry Changes: Analyst Raises Price Target
Benzinga
|
Unknown Analyst
Credit Suisse
|
100
USD
Upside 6% |
1 year ago
Feb 6, 2023
|
Credit Suisse Maintains Outperform on ArcBest, Raises Price Target to $100
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARCB's stock price target?
Price Target
124.78
USD
According to Wall Street analysts, the average 1-year price target for
ARCB
is 124.78 USD
with a low forecast of 106.05 USD and a high forecast of 178.5 USD.
What is ArcBest Corp's Revenue forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
ArcBest Corp's revenue is
7%.
The projected
CAGR
for the next 3 years is
3%.
What is ArcBest Corp's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
ArcBest Corp's operating income is
14%.
The projected
CAGR
for the next 3 years is
16%.
What is ArcBest Corp's Net Income forecast?
Projected CAGR
9%
For the last 8 years the
compound annual growth rate for
ArcBest Corp's net income is
20%.
The projected
CAGR
for the next 3 years is
9%.
You don't have any saved screeners yet
